Offshore law firm Appleby has acted as Jersey counsel to Advanz Pharma in connection with its sale to Nordic Capital for an equity value of $846m.
Pharmaceutical specialist Advanz Pharma is based in London but also has operations in Mumbai, commercial affiliates in North America, Europe and Australia, and a network of commercial partners across the world.
The acquisition is to be effected by way of a members' scheme of arrangement under Jersey company law. The acquisition is subject to regulatory approvals and is expected to close in the second quarter of 2021.
The global Appleby team was led by Partner Andrew Weaver and Senior Associate Kevin McQuillan, with Senior Associate Daniel Healy and Trainee Angharad Prescott assisting. They worked alongside law firms White & Case and Fasken Martineau DuMoulin.